Kenji Yamato

3.7k citations
86 papers · 3.1k indexed · h-index 33
Topics
Cancer-related Molecular Pathways (16 papers)TGF-β signaling in diseases (14 papers)T-cell and Retrovirus Studies (10 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Kenji Yamato

84 papers receiving 3.0k citations

Peers

Kenji Yamato
Comparison fields: 5 of 107
  • Molecular Biology 1.9k
  • Oncology 763
  • Immunology 542
  • Epidemiology 345
  • Cancer Research 328
Replace Nobumichi Hozumi with:
Nobumichi Hozumi Canada
A. Dobozy Hungary
Angela Gismondi Italy
Kazuhiro Morishita Japan
Karlheinz Friedrich Germany
John Hambor United States
Giichi Takaesu Japan
Moon Kyoo Jang United States
Klaus Degitz Germany
Ann M. Hopkins Ireland
Kenji Yamato relative to Nobumichi Hozumi Canada Nobumichi Hozumi's profile →
Citations per field
00.5×1.5×1.8×
Nobumichi Hozumi · 1×
Citations per year

Countries citing papers authored by Kenji Yamato

Since Specialization
Citations

This map shows the geographic impact of Kenji Yamato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Yamato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Yamato more than expected).

Fields of papers citing papers by Kenji Yamato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Yamato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Yamato. The network helps show where Kenji Yamato may publish in the future.

Co-authorship network of co-authors of Kenji Yamato

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Yamato. A scholar is included among the top collaborators of Kenji Yamato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Yamato. Kenji Yamato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 49
2 1
3 165
4 66
5 19
6 16
7 34
8 52
9 6
10 199
11 22
12 70
13 12
14 51
15 35
16 9
17 56
18 20
19 6
20 2

About Kenji Yamato

Kenji Yamato is a scholar working on Oncology, Immunology and Microbiology, having authored 86 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (16 papers), TGF-β signaling in diseases (14 papers) and T-cell and Retrovirus Studies (10 papers). The work is most often cited by research in Oncology (763 citations), Molecular Biology (1.9k citations) and Immunology (542 citations). Kenji Yamato has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Tatsuji Nishihara, Masahiro Kizaki, Yasuo Ikeda, Takeyoshi Koseki, Taketo Yamada, Tomonori Nakazato, Akira Ishisaki, Keisuke Ito, Masahiro Ohguchi and Nobuo Okahashi. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026